These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30291912)

  • 1. 11β-hydroxysteroid dehydrogenase type 1 inhibitor attenuates high-fat diet induced cardiomyopathy.
    Huang M; Liu J; Sheng Y; Lv Y; Yu J; Qi H; Di W; Lv S; Zhou S; Ding G
    J Mol Cell Cardiol; 2018 Dec; 125():106-116. PubMed ID: 30291912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11beta-hydroxysteroid dehydrogenase type 1 deficiency prevents memory deficits with aging by switching from glucocorticoid receptor to mineralocorticoid receptor-mediated cognitive control.
    Yau JL; Noble J; Seckl JR
    J Neurosci; 2011 Mar; 31(11):4188-93. PubMed ID: 21411659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
    Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
    Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice.
    Wang L; Liu J; Zhang A; Cheng P; Zhang X; Lv S; Wu L; Yu J; Di W; Zha J; Kong X; Qi H; Zhong Y; Ding G
    PLoS One; 2012; 7(7):e40056. PubMed ID: 22768329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
    Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
    Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
    Akiyama N; Akiyama Y; Kato H; Kuroda T; Ono T; Imagawa K; Asakura K; Shinosaki T; Murayama T; Hanasaki K
    J Pharmacol Exp Ther; 2014 Apr; 349(1):66-74. PubMed ID: 24511146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice.
    Li H; Sheng J; Wang J; Gao H; Yu J; Ding G; Ding N; He W; Zha J
    Drug Des Devel Ther; 2021; 15():2309-2324. PubMed ID: 34103895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Aldosterone Receptor Antagonist Eplerenone Inhibits Isoproterenol-Induced Collagen-I and 11β-HSD1 Expression in Rat Cardiac Fibroblasts and the Left Ventricle.
    Hori Y; Touei D; Saitoh R; Yamagishi M; Kanai K; Hoshi F; Itoh N
    Biol Pharm Bull; 2017; 40(10):1716-1723. PubMed ID: 28966243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction.
    Hirata A; Maeda N; Nakatsuji H; Hiuge-Shimizu A; Okada T; Funahashi T; Shimomura I
    Biochem Biophys Res Commun; 2012 Mar; 419(2):182-7. PubMed ID: 22326264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
    Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC
    Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential roles of 11β-HSD1 in regulating brown adipocyte function.
    Liu J; Kong X; Wang L; Qi H; Di W; Zhang X; Wu L; Chen X; Yu J; Zha J; Lv S; Zhang A; Cheng P; Hu M; Li Y; Bi J; Li Y; Hu F; Zhong Y; Xu Y; Ding G
    J Mol Endocrinol; 2013 Feb; 50(1):103-13. PubMed ID: 23197361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification.
    Zhu D; Rashdan NA; Chapman KE; Hadoke PW; MacRae VE
    Vascul Pharmacol; 2016 Nov; 86():87-93. PubMed ID: 27153999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated rats.
    Hu GX; Lin H; Lian QQ; Zhou SH; Guo J; Zhou HY; Chu Y; Ge RS
    PLoS One; 2013; 8(3):e49976. PubMed ID: 23533564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells.
    Chantong B; Kratschmar DV; Nashev LG; Balazs Z; Odermatt A
    J Neuroinflammation; 2012 Nov; 9():260. PubMed ID: 23190711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes.
    Rossier MF; Python M; Maturana AD
    Endocrinology; 2010 Jun; 151(6):2777-87. PubMed ID: 20392829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.
    Iqbal J; Macdonald LJ; Low L; Seckl JR; Yau CW; Walker BR; Hadoke PW
    Endocrinology; 2012 Dec; 153(12):5896-905. PubMed ID: 23125311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of mineralocorticoid and glucocorticoid receptors in preautonomic neurons of the rat paraventricular nucleus.
    Chen J; Gomez-Sanchez CE; Penman A; May PJ; Gomez-Sanchez E
    Am J Physiol Regul Integr Comp Physiol; 2014 Mar; 306(5):R328-40. PubMed ID: 24381176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 ameliorates obesity-related insulin resistance.
    Shao S; Zhang X; Zhang M
    Biochem Biophys Res Commun; 2016 Sep; 478(1):474-480. PubMed ID: 27268236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal elevation of β-cell 11β-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced β-cell failure.
    Turban S; Liu X; Ramage L; Webster SP; Walker BR; Dunbar DR; Mullins JJ; Seckl JR; Morton NM
    Diabetes; 2012 Mar; 61(3):642-52. PubMed ID: 22315313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.